Literature DB >> 16122636

Prenatal stroke in a neonate heterozygous for factor V Leiden mutation.

Alfonso Verdu1, María R Cazorla, Juan C Moreno, Luis F Casado.   

Abstract

The authors report an infant with congenital hemiplegia associated to heterozygosity for factor V Leiden. Prenatal stroke in the left cerebral hemisphere was diagnosed by ultrasonography at the 28th week of pregnancy, and followed up until birth. Although neonatal neurologic examination was normal, a moderate right hemiparesis developed along the 1st months of life. Coagulation studies performed in the neonatal period and at the age of 18 months revealed activated protein C resistance due to factor V Leiden mutation (R506Q). There are some previous reports of stroke associated to this mutation in near or at term neonates, but to our knowledge this is the stroke detected at the most early stage of fetal development.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16122636     DOI: 10.1016/j.braindev.2004.10.004

Source DB:  PubMed          Journal:  Brain Dev        ISSN: 0387-7604            Impact factor:   1.961


  3 in total

1.  Clinical presentations and neurodevelopmental outcomes of perinatal stroke in preterm and term neonates: a case series.

Authors:  Hyun Ju Lee; Byung Chan Lim; Hee Hwang; Joon-Seok Hong; Ee-Kyung Kim; Han-Suk Kim; Beyong Il Kim; Jung-Hwan Choi; Chang Won Choi
Journal:  J Korean Med Sci       Date:  2010-05-24       Impact factor: 2.153

2.  Neonatal pulmonary artery thrombosis presenting as persistent pulmonary hypertension of the newborn.

Authors:  Taylor Sawyer; Amanda Antle; Matthew Studer; Mark Thompson; Stanton Perry; C Becket Mahnke
Journal:  Pediatr Cardiol       Date:  2008-12-04       Impact factor: 1.655

Review 3.  Genetic Profiling of Idiopathic Antenatal Intracranial Haemorrhage: What We Know?

Authors:  Anna Franca Cavaliere; Irene Turrini; Marta Pallottini; Annalisa Vidiri; Laura Marchi; Federica Perelli; Simona Zaami; Giovanni Scambia; Fabrizio Signore
Journal:  Genes (Basel)       Date:  2021-04-15       Impact factor: 4.096

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.